A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea – dose optimization, clinical outcomes, and CD4+ T cell responses-Reference-Cited by-同舟云学术

A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea – dose optimization, clinical outcomes, and CD4+ T cell responses

Published:2019-10-30 Issue:10 Volume:13 Page:e0007823
ISSN:1935-2735
Container-title:PLOS Neglected Tropical Diseases
language:en
Short-container-title:PLoS Negl Trop Dis

Author:

Sakkestad Sunniva Todnem^ORCID,Steinsland Hans,Skrede Steinar,Lillebø Kristine,Skutlaberg Dag Harald^ORCID,Guttormsen Anne Berit,Zavialov Anton,Paavilainen Sari,Søyland Hanne,Sævik Marianne,Heien Astrid Rykkje,Tellevik Marit Gjerde,Barry Eileen,Langeland Nina,Sommerfelt Halvor,Hanevik Kurt^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference39 articles.

1. Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016;IA Khalil;Lancet Infect Dis,2018

2. Etiology of travellers' diarrhea;ZD Jiang;J Travel Med,2017

3. Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study;ET Rogawski;Lancet Glob Health,2018

4. Early childhood cognitive development is affected by interactions among illness, diet, enteropathogens and the home environment: findings from the MAL-ED birth cohort study;Investigators M-EN;BMJ Glob Health,2018

5. An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children;RI Walker;Vaccine,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens;Frontiers in Immunology;2024-09-11

2. Inflammation, the kynurenines, and mucosal injury during human experimental enterotoxigenic Escherichia coli infection;Medical Microbiology and Immunology;2024-03-02

3. The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops;Vaccine;2023-11

4. T helper cell responses in adult diarrheal patients following natural infection with enterotoxigenic Escherichia coli are primarily of the Th17 type;Frontiers in Immunology;2023-09-20

5. Reduced Plasma Guanylin Levels Following Enterotoxigenic Escherichia coli-Induced Diarrhea;Microorganisms;2023-08-03